LYNN CAROLLO: Open Payments
NPI 1518300177 · HIGHLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,570 in 134 payments from 18 companies in 2025. Trend: 2023 $2,946 · 2024 $3,019 · 2025 $2,570
Food & beverage: $2,475Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $804 |
| Janssen Biotech, Inc. | 16 | $394 |
| Gilead Sciences, Inc. | 12 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $200 |
| PFIZER INC. | 8 | $138 |
| Ardelyx, Inc. | 4 | $101 |
| Celltrion USA Inc. | 6 | $98 |
| Ipsen Biopharmaceuticals, Inc | 4 | $98 |
| GENZYME CORPORATION | 3 | $93 |
| Exact Sciences Corporation | 3 | $79 |
Products named: TREMFYA, RINVOQ, CREON, LINZESS, XELJANZ, DUPIXENT, IBSRELA, GATTEX.
Industry payments across NY — which companies pay providers there.
